Literature DB >> 1799407

Recombinant human hemoglobin: expression and refolding of beta-globin from Escherichia coli.

C Fronticelli1, J K O'Donnell, W S Brinigar.   

Abstract

A plasmid analogous to the one described by Nagai and Thogersen (Nature, 309, 810-812, 1984) has been constructed for the expression of globins in E. coli. Induction with nalidixic acid produces high yields of a fusion protein, NS1-FX-beta-globin, where NS1 represents 81 residues of a flu virus protein and FX represents a blood-clotting Factor Xa recognition sequence, Ile-Glu-Gly-Arg. This fusion protein is readily solubilized in 50 mM NaOH and remains in solution when the pH is adjusted to 8.6. Under these conditions, the fusion protein is hydrolyzed by activated Factor X, giving authentic beta-globin which can be folded in the presence of cyanohemin and native alpha-chains to produce a tetrameric hemoglobin with the functional properties of natural human hemoglobin.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1799407     DOI: 10.1007/BF01025477

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  18 in total

1.  A NEW METHOD FOR THE PREPARATION OF ALPHA AND BETA SUBUNITS OF HUMAN HEMOGLOBIN.

Authors:  E BUCCI; C FRONTICELLI
Journal:  J Biol Chem       Date:  1965-01       Impact factor: 5.157

2.  Characterization of haem disorder by circular dichroism.

Authors:  H S Aojula; M T Wilson; A Drake
Journal:  Biochem J       Date:  1986-07-15       Impact factor: 3.857

3.  On the determination of species fractions from ligand-binding data. Application to human hemoglobin.

Authors:  E Di Cera; S J Gill
Journal:  Biophys Chem       Date:  1988-04       Impact factor: 2.352

4.  Molecular weight analysis of oligopeptides by electrophoresis in polyacrylamide gel with sodium dodecyl sulfate.

Authors:  R T Swank; K D Munkres
Journal:  Anal Biochem       Date:  1971-02       Impact factor: 3.365

5.  Synthesis and sequence-specific proteolysis of hybrid proteins produced in Escherichia coli.

Authors:  K Nagai; H C Thøgersen
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

6.  Heme orientational disorder in reconstituted and native sperm whale myoglobin. Proton nuclear magnetic resonance characterizations by heme methyl deuterium labeling in the Met-cyano protein.

Authors:  G N La Mar; N L Davis; D W Parish; K M Smith
Journal:  J Mol Biol       Date:  1983-08-25       Impact factor: 5.469

7.  Membrane-covered thin-layer optical cell for gas-reaction studies of hemoglobin.

Authors:  D Dolman; S J Gill
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

8.  Oxygen binding constants for human hemoglobin tetramers.

Authors:  S J Gill; E Di Cera; M L Doyle; G A Bishop; C H Robert
Journal:  Biochemistry       Date:  1987-06-30       Impact factor: 3.162

9.  Oxygen binding properties of human mutant hemoglobins synthesized in Escherichia coli.

Authors:  K Nagai; M F Perutz; C Poyart
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Generation of beta-globin by sequence-specific proteolysis of a hybrid protein produced in Escherichia coli.

Authors:  K Nagai; H C Thøgersen
Journal:  Nature       Date:  1984 Jun 28-Jul 4       Impact factor: 49.962

View more
  3 in total

1.  Two mutations in recombinant Hb beta F41(C7)Y, K82 (EF6)D show additive effects in decreasing oxygen affinity.

Authors:  A Dumoulin; L Kiger; N Griffon; C Vasseur; I Kister; P Génin; M C Marden; J Pagnier; C Poyart
Journal:  Protein Sci       Date:  1996-01       Impact factor: 6.725

Review 2.  Development of recombinant hemoglobin-based oxygen carriers.

Authors:  Cornelius L Varnado; Todd L Mollan; Ivan Birukou; Bryan J Z Smith; Douglas P Henderson; John S Olson
Journal:  Antioxid Redox Signal       Date:  2012-11-16       Impact factor: 8.401

3.  Cysteines beta93 and beta112 as probes of conformational and functional events at the human hemoglobin subunit interfaces.

Authors:  G B Vásquez; M Karavitis; X Ji; I Pechik; W S Brinigar; G L Gilliland; C Fronticelli
Journal:  Biophys J       Date:  1999-01       Impact factor: 4.033

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.